<DOC>
	<DOCNO>NCT00855010</DOCNO>
	<brief_summary>Randomized , double blind , placebo control trial evaluate effect pioglitazone pancreatic fat content bone turnover marker .</brief_summary>
	<brief_title>Pioglitazone Pancreatic Steatosis Bone Health</brief_title>
	<detailed_description />
	<mesh_term>Pioglitazone</mesh_term>
	<criteria>Fat level pancreas 4 % ( measurement do u MRI ) English speaker 21 year old contraindication MRI anemia pregnancy desire conceive use unapproved medication prior pancreatic disease use 2 alcoholic drink every day</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>Pioglitazone</keyword>
	<keyword>prediabetes</keyword>
	<keyword>diabetes</keyword>
	<keyword>obesity</keyword>
	<keyword>Pancreatic fat</keyword>
</DOC>